Transmedics Group Inc
NASDAQ:TMDX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
60.53
176.11
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Transmedics Group Inc
Wall Street
Price Targets
TMDX Price Targets Summary
Transmedics Group Inc
According to Wall Street analysts, the average 1-year price target for
TMDX
is 113.86 USD
with a low forecast of 75.75 USD and a high forecast of 187.95 USD.
TMDX Last Price Targets
Transmedics Group Inc
The latest public price target was made on Oct 29, 2024 by
Suraj Kalia
from
Oppenheimer
,
who expects
TMDX
stock to
rise by 96%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Suraj Kalia
Oppenheimer
|
125
USD
Upside 96% |
1 month ago
Oct 29, 2024
|
TransMedics Group (TMDX) PT Lowered to $125 at Oppenheimer
StreetInsider
|
Mike Matson
Needham
|
109
USD
Upside 71% |
1 month ago
Oct 29, 2024
|
TransMedics Group (TMDX) PT Lowered to $109 at Needham
StreetInsider
|
Joe Vruwink
Robert W. Baird
|
150
USD
Upside 135% |
1 month ago
Oct 29, 2024
|
TransMedics Group (TMDX) PT Lowered to $150 at Baird
StreetInsider
|
Jason Mills
Canaccord Genuity
|
109
USD
Upside 71% |
1 month ago
Oct 29, 2024
|
TransMedics Group (TMDX) PT Lowered to $109 at Canaccord Genuity
StreetInsider
|
|
David Rescott
Robert W. Baird
|
200
USD
Upside 213% |
3 months ago
Sep 23, 2024
|
TransMedics initiated with an Outperform at Baird
TheFly
|
Matt O'Brien
Piper Sandler
|
180
USD
Upside 182% |
3 months ago
Sep 4, 2024
|
Piper Sandler Reiterates Overweight Rating on TransMedics Group (TMDX)
StreetInsider
|
|
Mike Matson
Needham
|
208
USD
Upside 226% |
4 months ago
Aug 21, 2024
|
TransMedics initiated with a Buy at Needham
TheFly
|
|
Suraj Kalia
Oppenheimer
|
200
USD
Upside 213% |
4 months ago
Aug 1, 2024
|
TransMedics price target raised to $200 from $125 at Oppenheimer
TheFly
|
|
William Plovanic
Canaccord Genuity
|
169
USD
Upside 164% |
4 months ago
Aug 1, 2024
|
TransMedics price target raised to $169 from $117 at Canaccord
TheFly
|
|
Matt O'Brien
Piper Sandler
|
170
USD
Upside 166% |
5 months ago
Jul 15, 2024
|
TransMedics price target raised to $170 from $120 at Piper Sandler
TheFly
|
Patrick Wood
Morgan Stanley
|
145
USD
Upside 127% |
5 months ago
Jul 15, 2024
|
TransMedics price target raised to $145 from $104 at Morgan Stanley
TheFly
|
|
George Sellers
Stephens
|
151
USD
Upside 136% |
6 months ago
Jun 3, 2024
|
Stephens Starts TransMedics Group (TMDX) at Overweight
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TMDX's stock price target?
Price Target
113.86
USD
According to Wall Street analysts, the average 1-year price target for
TMDX
is 113.86 USD
with a low forecast of 75.75 USD and a high forecast of 187.95 USD.
What is Transmedics Group Inc's Revenue forecast?
Projected CAGR
36%
For the last 6 years the
compound annual growth rate for
Transmedics Group Inc's revenue is
78%.
The projected
CAGR
for the next 4 years is
36%.
What is Transmedics Group Inc's Operating Income forecast?
Projected CAGR
335%
The
compound annual growth rate
of Transmedics Group Inc's operating income for the next 4 years is
335%.
You don't have any saved screeners yet
